Clinical Outcomes and Risk Factors of Rebleeding Following Endoscopic Therapy for Nonvariceal Upper Gastrointestinal Hemorrhage

다국어 초록 (Multilingual Abstract)

Background/Aims: Rebleeding after endoscopic therapy for non-variceal upper gastrointestinal hemorrhage (NGIH) is the most important predictive factor of mortality. We evaluated the risk factors of rebleeding in patients undergoing endoscopic therapy for the NGIH.
Methods: Between January 2003 and January 2007, 554 bleeding events in 487 patients who underwent endoscopic therapy for NGIH were retrospectively enrolled. We reviewed the clinicoendoscopical characteristics of patients with rebleeding and compared them with those of patients without rebleeding.
Results: The incidence of rebleeding was 21.7% (n=120). In the multivariate analysis, initial hemoglobin level ≤9 g/dL (p=0.002; odds ratio [OR], 2.433), inexperienced endoscopist with less than 2 years of experience in therapeutic endoscopy (p=0.001; OR, 2.418), the need for more 15 cc of epinephrine (p=0.001; OR, 2.570), injection therapy compared to thermal and injection therapy (p=0.001; OR, 2.840), and comorbidity with chronic renal disease (p=0.004; OR, 2.908) or liver cirrhosis (p=0.010; OR, 2.870) were risk factors for rebleeding following endoscopic therapy.
Conclusions: Together with patients with low hemoglobin level at presentation, chronic renal disease, liver cirrhosis, the need for more 15 cc of epinephrine, or therapy done by inexperienced endoscopist were risk factors for the development of rebleeding.

참고문헌 (Reference)

1 Andriulli A, "Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses" 100 : 207-219, 2005

2 Tajima A, "Proton pump inhibitors and recurrent bleeding in peptic ulcer disease" 23 (23): S237-S241, 2008

3 Hu ML, "Predictors of rebleeding after initial hemostasis with epinephrine injection in high-risk ulcers" 16 : 5490-5495, 2010

4 Chiu PW, "Predictors of peptic ulcer rebleeding after scheduled second endoscopy: clinical or endoscopic factors?" 38 : 726-729, 2006

5 Marmo R, "Predictive factors of mortality from nonvariceal upper gastrointestinal hemorrhage: a multicenter study" 103 : 1639-1647, 2008

6 Wong SK, "Prediction of therapeutic failure after adrenaline injection plus heater probe treatment in patients with bleeding peptic ulcer" 50 : 322-325, 2002

7 Chiu PW, "Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy" 7 : 311-316, 2009

8 Cheung J, "Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease" 71 : 44-49, 2010

9 Barkun A, "Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding" 139 : 843-857, 2003

10 Müller T, "Non-variceal upper GI bleeding in patients already hospitalized for another condition" 104 : 330-339, 2009

11 Sung JJ, "Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial" 150 : 455-464, 2009

12 Barkun AN, "International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding" 152 : 101-113, 2010

13 Wolf AT, "Impact of anticoagulation on rebleeding following endoscopic therapy for nonvariceal upper gastrointestinal hemorrhage" 102 : 290-296, 2007

14 Vallurupalli NG, "Gastrointestinal complications of dual antiplatelet therapy" 113 : e655-e658, 2006

15 Ng FH, "Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome" 103 : 865-871, 2008

16 Dinoso VP, "Gastric and pancreatic function in patients with end-stage renal disease" 4 : 321-324, 1982

17 Peters RJ, "Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study" 108 : 1682-1687, 2003

18 Kaviani MJ, "Effect of oral omeprazole in reducing re-bleeding in bleeding peptic ulcers: a prospective, double-blind, randomized, clinical trial" 17 : 211-216, 2003

19 Lau JY, "Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers" 343 : 310-316, 2000

20 Chan FK, "Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding" 352 : 238-244, 2005

21 Laine L, "Bleeding peptic ulcer" 331 : 717-727, 1994

22 Lin HJ, "A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy" 158 : 54-58, 1998